Trial Profile
A Phase II Study of Preoperative Systemic Chemotherapy (Modified FOLFIRINOX) Followed by Radiation Therapy for Patients With High Risk Resectable and Borderline Resectable Adenocarcinoma of the Pancreas
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Fluorouracil (Primary) ; Gemcitabine (Primary) ; Irinotecan (Primary) ; Oxaliplatin (Primary)
- Indications Adenocarcinoma; Pancreatic cancer
- Focus Therapeutic Use
- 18 Mar 2019 Status changed from active, no longer recruiting to completed.
- 19 Mar 2018 Planned End Date changed from 1 Jun 2019 to 1 Jun 2021.
- 19 Mar 2018 Planned primary completion date changed from 1 Jun 2019 to 1 Jun 2020.